比较效果研究最终会成功吗？
Will comparative effectiveness research finally succeed?
作者信息
Blackstone Erwin A, Fuhr Joseph P, Ziernicki Danielle
出版信息
Biotechnol Healthc. 2012 Fall;9(3):22-6.
Abstract
Autonomy, innovation, and drug access may be at stake along with personalized medicine. Can all stakeholders be satisfied and should cost be a factor?
摘要
自主性、创新性以及药物可及性可能与个性化医疗一并受到影响。所有利益相关者能都满意吗？成本应该成为一个考量因素吗？
相似文献
1
Will comparative effectiveness research finally succeed?
Biotechnol Healthc. 2012 Fall;9(3):22-6.
2
3
Personalized medicine and comparative effectiveness research in an era of fixed budgets.
EPMA J. 2010 Dec;1(4):633-40. doi: 10.1007/s13167-010-0058-6. Epub 2010 Dec 8.
4
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):330-40. doi: 10.1016/j.zefq.2015.06.012. Epub 2015 Jul 28.
5
Comparative effectiveness research and personalized medicine: catalyzing or colliding?
Pharmacoeconomics. 2010;28(10):905-13. doi: 10.2165/11535830-000000000-00000.
6
Comparative effectiveness and personalized medicine: evolving together or apart?
Health Aff (Millwood). 2010 Oct;29(10):1783-7. doi: 10.1377/hlthaff.2010.0642.
7
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
Value Health. 2013 Sep-Oct;16(6 Suppl):S1-3. doi: 10.1016/j.jval.2013.06.004.
9
Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.
Health Aff (Millwood). 2006 Sep-Oct;25(5):1281-90. doi: 10.1377/hlthaff.25.5.1281.
10
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.
J Clin Oncol. 2012 Dec 1;30(34):4233-42. doi: 10.1200/JCO.2012.42.6114. Epub 2012 Oct 15.
引用本文的文献
1
Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges.
Front Med (Lausanne). 2020 Oct 16;7:582634. doi: 10.3389/fmed.2020.582634. eCollection 2020.
2
The landscape of comparative effectiveness research in rheumatology.
Nat Rev Rheumatol. 2014 Jan;10(1):57-62. doi: 10.1038/nrrheum.2013.140. Epub 2013 Sep 24.
本文引用的文献
1
Can CER be an effective tool for change in the development and assessment of new drugs and technologies?
J Manag Care Pharm. 2012 Jun;18(5 Supp A):S06-11. doi: 10.18553/jmcp.2012.18.s5-a.S06.
2
Translating comparative effectiveness research into clinical practice: the UK experience.
Drugs. 2012 Jan 22;72(2):163-70. doi: 10.2165/11630860-000000000-00000.
3
A regulator's view of comparative effectiveness research.
Clin Trials. 2012 Feb;9(1):56-65. doi: 10.1177/1740774511422548. Epub 2011 Oct 5.
4
An introduction to comparative effectiveness research.
Neurosurgery. 2012 Feb;70(2):425-34; discussion 434. doi: 10.1227/NEU.0b013e3182320a9e.
5
Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticals.
Future Med Chem. 2010 Nov;2(11):1641-9. doi: 10.4155/fmc.10.248.
6
Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.
Mayo Clin Proc. 2009 Aug;84(8):675-84. doi: 10.4065/84.8.675.
7
Comparative-effectiveness research--implications of the Federal Coordinating Council's report.
N Engl J Med. 2009 Jul 23;361(4):328-30. doi: 10.1056/NEJMp0905631. Epub 2009 Jun 30.
8
Comparative effectiveness research: a report from the Institute of Medicine.
Ann Intern Med. 2009 Aug 4;151(3):203-5. doi: 10.7326/0003-4819-151-3-200908040-00125. Epub 2009 Jun 30.
9
The neglected purpose of comparative-effectiveness research.
N Engl J Med. 2009 May 7;360(19):1929-31. doi: 10.1056/NEJMp0902195.
10
Does comparative-effectiveness research threaten personalized medicine?
N Engl J Med. 2009 May 7;360(19):1925-7. doi: 10.1056/NEJMp0901355.
Zotero 插件